Jack Nathan Medical Corp.
Jack Nathan Medical Corp. Fundamental Analysis
Jack Nathan Medical Corp. (JNHMF) shows weak financial fundamentals with a PE ratio of 0.10, profit margin of -6.29%, and ROE of -101.83%. The company generates $-0.0B in annual revenue with weak year-over-year growth of -54.52%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -10687.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze JNHMF's fundamental strength across five key dimensions:
Efficiency Score
ExcellentJNHMF demonstrates superior asset utilization.
Valuation Score
ExcellentJNHMF trades at attractive valuation levels.
Growth Score
ModerateJNHMF shows steady but slowing expansion.
Financial Health Score
ModerateJNHMF shows balanced financial health with some risks.
Profitability Score
WeakJNHMF struggles to sustain strong margins.
Key Financial Metrics
Is JNHMF Expensive or Cheap?
P/E Ratio
JNHMF trades at 0.10 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, JNHMF's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Jack Nathan Medical Corp. at -0.52 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -1.97 times EBITDA. This is generally considered low.
How Well Does JNHMF Make Money?
Net Profit Margin
For every $100 in sales, Jack Nathan Medical Corp. keeps $-6.29 as profit after all expenses.
Operating Margin
Core operations generate 32.41 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-101.83 in profit for every $100 of shareholder equity.
ROA
Jack Nathan Medical Corp. generates $20.46 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Jack Nathan Medical Corp. generates strong operating cash flow of $-1.87M, reflecting robust business health.
Free Cash Flow
Jack Nathan Medical Corp. generates strong free cash flow of $-2.45M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $-0.03 in free cash annually.
FCF Yield
JNHMF converts -2.31% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
0.10
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.52
vs 25 benchmark
P/S Ratio
Price to sales ratio
-0.62
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-0.10
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.11
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-101.83
vs 25 benchmark
ROA
Return on assets percentage
20.46
vs 25 benchmark
ROCE
Return on capital employed
0.39
vs 25 benchmark
How JNHMF Stacks Against Its Sector Peers
| Metric | JNHMF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 0.10 | 29.43 | Better (Cheaper) |
| ROE | -10182.51% | 684.00% | Weak |
| Net Margin | -629.33% | -45067.00% (disorted) | Weak |
| Debt/Equity | -0.10 | 0.43 | Strong (Low Leverage) |
| Current Ratio | 0.11 | 4.07 | Weak Liquidity |
| ROA | 2045.73% | -17158.00% (disorted) | Strong |
JNHMF outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Jack Nathan Medical Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-53.10%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
115.64%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-1884.21%
Industry Style: Defensive, Growth, Innovation
Declining